Top Markets
Coin of the day
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
주식 순위 #40868
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
주가
$0.02765
마지막 동기화: 2024-12-23
시가총액
$69.04K
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Histogen Inc. (HSTO)

카테고리

Histogen Inc. (HSTO)의 P/B 비율
August 2026 기준 P/B 비율 TTM: 0.00
Histogen Inc.의 최신 재무 보고서와 주가에 따르면 현재 P/B 비율(TTM)은 0.00입니다. 2021년 말 기준 P/B 비율은 0.06였습니다.
Histogen Inc.의 P/B 비율 기록 (2011 ~ 2026)
매년 말 P/B 비율
연도 P/B 비율 변화
2026 (TTM) 0.00 -77.50%
2022 0.02 -69.01%
2021 0.06 -31.54%
2020 0.09 -168.39%
2019 -0.13 -166.48%
2018 0.19 -59.34%
2017 0.47 -13.89%
2016 0.55 -98.24%
2015 31.05 -52.41%
2014 65.25 265.13%
2013 17.87 0.00%
2012 0.00 0.00%
2011 0.00 0.00%
유사 기업 또는 경쟁사의 P/B 비율
회사 P/B 비율 P/B 비율 차이 국가
6.2613 139,040.00%
US
6.3483 140,973.33%
NL
- -
CH
- -
KR
3.634 80,655.56%
BE